 |
 |
 |
 |
 |
 |
Milestones
Products Gallery |
 |
Jintropin™ rhGH for injection |
 |
| Somatropin Liquid Pen Jintropin™ AQ rhGH injection 15, 30 IU/3ml cartridge |
 |
| GenLei™ Scimax™ Filgrastim/rhG-CSF injection 75,150,200,300 µg per vial |
 |
| GenLei™ Granmac™ rhGM-CSF for injection 75,150,300 µg per vial |
 |
| GenLei™ Jintrotide™ Octreotide acetate for injection 0.1,0.3 mg per vial |
 |
| GenLei™ Jintrirelin™ Triptorelin acetate injection 0.1 mg per vial |
| Click pic for more details |
1996.1 |
Company founded. | ||||
1997.9 |
Manufacturing facilities completed. GenSci became the biopharmaceutical company with the largest manufacturing capacity in China. |
||||
1997.12 |
GenLei™ Jintropin™ and GenLei™ Scimax™ were listed as one of the key projects of the National 9th Five Year Plan by the State Planning Commission. | ||||
1998.2 |
GenLei™ Jintropin™ was officially approved by the Chinese Ministry of Health and become the first somatropin made by a domestic company. | ||||
1998.5 |
GenLei™ Scimax™ was officially approved by the Chinese Ministry of Health and became the only G-CSF made by E.coli secretion technology in the world. | ||||
2002 |
GenLei TMJintropin TMhas been the leading brand of hGH with more than 67% market share (IMS survey, 2002) | ||||
2004.9 |
A new manufacturing facility with 12000m2 production floor space was complete which is capable of producing 3 million vials of lyophilized preparations and 5 million vials of liquid preparations annually. |
||||
2004.10 |
GenLei™ Jintrotide™ and GenLei™ Jintrirelin™ were formally approved for marketing by the SFDA. |
||||
2005.3 |
GenLei™ Jintropin™ AQ liquid formulation was formally approved. It is found to raise no antibody in patients and is regarded as the best quality of hGH in China. |
||||
2006.1 |
GenSci was ranked top 1 for its 2005 profit among all Chinese biopharmaceutical companies focused on recombinant products. | ||||
|
|||||
